Avicella Capital

Venture Capital Washington, United States ·Founded 2024

Overview

Avicella Capital is a U.S.-based venture capital firm specializing in healthcare investments. The firm focuses on identifying and financing innovative, ethically-driven ventures that aim to improve patient outcomes and elevate healthcare standards. It concentrates on sectors such as therapeutics, medical devices, diagnostics, and health technology. The firm's investment strategy is dedicated to investing in cutting-edge medical technologies and therapies that have the potential to revolutionize healthcare, decrease morbidity, improve quality of life, and extend human lifespan. Avicella Capital seeks companies that improve healthcare outcomes by utilizing real-time data and sophisticated AI methodologies, as well as optimizing workflow to address evolving healthcare challenges. Avicella Capital has a track record of supporting innovative healthcare companies. Recent investments include Convergence Medical Robotics, which secured a $5 million Series A funding round in January 2025, and Faeth Therapeutics, which received a $25 million Series B investment in October 2025. These investments reflect the firm's commitment to advancing healthcare through strategic partnerships and funding.

Investment Focus

  • Innovative healthcare solutions
  • Established proof-of-concept
  • Ethically-driven ventures

Portfolio Companies

Faeth TherapeuticsConvergence Medical Robotics

Reach Avicella Capital directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about Avicella Capital

What sectors does Avicella Capital invest in?

Avicella Capital invests in Healthcare, Pharmaceuticals, Medical Devices, Biotechnology, Therapeutics and Health Diagnostics, and is based in Washington, United States. Avicella Capital is listed as a venture capital in the ConnectSafely investor database.

What stage does Avicella Capital invest at?

Avicella Capital backs companies at Seed, Early Stage, Series A and Series B, writing cheques of 500K - 20M.

Which regions does Avicella Capital invest in?

Avicella Capital invests across United States, Australia and Europe.

What companies has Avicella Capital invested in?

Avicella Capital's portfolio includes Faeth Therapeutics and Convergence Medical Robotics.

Last updated · Source: ConnectSafely investor database